本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pharming Group N.V.

10.55
-0.2300-2.13%
盤後10.550.00000.00%16:10 EDT
成交量:7,852
成交額:8.34萬
市值:7.45億
市盈率:83.37
高:10.75
開:10.72
低:10.50
收:10.78
52周最高:21.34
52周最低:9.62
股本:7,062.52萬
流通股本:6,950.40萬
量比:0.29
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):0.1266
每股收益(LYR):0.0400
淨資產收益率:3.65%
總資產收益率:3.47%
市淨率:2.75
市盈率(LYR):263.75

資料載入中...

2026/04/13

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2026/04/02

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/03

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/04/05

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/06

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/07

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/12/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/22

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/17

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/11/25

招股説明書

F-1 - Registration statement for certain foreign private issuers